ArticleMolecular oncology2024

Targeting metabolic reprogramming to overcome drug resistance in advanced bladder cancer: insights from gemcitabine- and cisplatin-resistant models.

Ichiro Kawahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.